|
|
|||
|
||||
OverviewRadioactive drug development is a multi-disciplinary task, therefore, in a concerted effort, dedicated scientists and experts from different fields of specialisation have contributed to this book. It is presented in two sections. Section 1 contains basic principles and methods used for analysis, information on the chemistry of technetium and on radiopharmaceuticals labelled with technetium-99m, the characteristics of the 99 Mo/99mTc-generator, of 'kits' and formulations for in-vitro labelling, and special safety aspects for in-vivo labelling of blood cells. Section 2 contains monographs of 99mTc-radiopharmaceuticals used in nuclear medicine. Each monograph includes information on the chemistry, formulation, commercial products and trade names, factors affecting in-vivo performance, clinical information on pharmacokinetics, as well as details concerning the clinical application and the radiation dose to patients. Full Product DetailsAuthor: Ilse ZollePublisher: Springer-Verlag Berlin and Heidelberg GmbH & Co. KG Imprint: Springer-Verlag Berlin and Heidelberg GmbH & Co. K Edition: 2007 ed. Dimensions: Width: 15.50cm , Height: 2.00cm , Length: 23.50cm Weight: 0.717kg ISBN: 9783540339892ISBN 10: 3540339892 Pages: 345 Publication Date: 07 November 2006 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsFrom the reviews: This nicely organized and clearly illustrated book provides an up-to-date resource for radiopharmacists and nuclear medicine physicians who compound and prescribe 99mTc-labeled radiopharmaceuticals. Radiochemists and those concerned with regulatory affairs also will be interested, and the book could be used as a primary text in nuclear medicine training programs. This outstanding book fills a void and is the first compilation of its kind in many years. We recommend it with the highest enthusiasm. (Susan Z. Lever and John R. Lever, Journal of Nuclear Medicine, May, 2009) Aus den Rezensionen: ! Die Abschnitte sind uberaus sorgfaltig und ubersichtlich gestaltet und stecken auch voller praktischer Tipps. Das Buch tragt umfassend bei zum Verstandnis der Technetiumchemie und --pharmazie und somit zur Sicherung der Sachkunde im Umgang mit radioaktiven Arzneimitteln. Der Bruckenschlag zur taglichen klinischen Nutzung ist sehr gut gelungen. Das Buch sollte uberall dort zur Verfugung stehen, wo technetiummarkierte radioaktive Arzneimittel hergestellt und/oder verwendet werden ! (U. Bull, in: Nuklearmedizin, 2008, Vol. 47, Issue 1, S. N10) Author InformationTab Content 6Author Website:Countries AvailableAll regions |